Axsome Therapeutics Inc (AXSM) — Defensive Interval Ratio
Axsome Therapeutics Inc (AXSM) has a Defensive Interval Ratio of 220 days as of June 2026. Defensive assets of $277.46 Million (cash $-, short-term investments $-, receivables $277.46 Million) cover 220 days of daily cash needs of $1.26 Million/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Axsome Therapeutics Inc Defensive Interval Ratio (2016–2025)
This chart shows how Axsome Therapeutics Inc's Defensive Interval Ratio has evolved across 7 annual periods from 2016 to 2025. As of June 2026, the ratio stands at 220 days, meaning defensive assets of $277.46 Million can fund 220 days of operations without new revenue. For the complete balance sheet picture, see balance sheet size of Axsome Therapeutics Inc.
Annual Defensive Interval Ratio for Axsome Therapeutics Inc (2016–2025)
The table below presents the year-by-year Defensive Interval Ratio for Axsome Therapeutics Inc from 2016 to 2025, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Axsome Therapeutics Inc (AXSM) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 216 days | $224.46 Million | $1.04 Million/day | $- | $- | ▼ -9 days |
| 2024 | 225 days | $142.00 Million | $630.42K/day | $- | $- | ▼ -24 days |
| 2023 | 249 days | $94.82 Million | $380.42K/day | $- | $- | ▲ +107 days |
| 2022 | 143 days | $37.70 Million | $264.55K/day | $- | $- | ▲ +143 days |
| 2021 | 0 days | $0.00 | $63.19K/day | $- | $- | ▲ +0 days |
| 2017 | 0 days | $0.00 | $33.36K/day | $- | $0.00 | ▲ +0 days |
| 2016 | 0 days | $0.00 | $19.65K/day | $- | $0.00 | — |